Fulgent Genetics (FLGT) Share-based Compensation (2016 - 2026)
Fulgent Genetics' Share-based Compensation history spans 11 years, with the latest figure at $9.9 million for Q1 2026.
- On a quarterly basis, Share-based Compensation fell 6.26% to $9.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $38.9 million, a 10.55% decrease, with the full-year FY2025 number at $39.6 million, down 11.01% from a year prior.
- Share-based Compensation hit $9.9 million in Q1 2026 for Fulgent Genetics, up from $9.3 million in the prior quarter.
- Over the last five years, Share-based Compensation for FLGT hit a ceiling of $11.6 million in Q2 2024 and a floor of $5.6 million in Q1 2022.
- Historically, Share-based Compensation has averaged $10.0 million across 5 years, with a median of $10.3 million in 2023.
- Biggest five-year swings in Share-based Compensation: surged 127.74% in 2022 and later dropped 13.72% in 2025.
- Tracing FLGT's Share-based Compensation over 5 years: stood at $10.0 million in 2022, then grew by 14.07% to $11.4 million in 2023, then fell by 8.96% to $10.4 million in 2024, then fell by 10.88% to $9.3 million in 2025, then grew by 6.62% to $9.9 million in 2026.
- Business Quant data shows Share-based Compensation for FLGT at $9.9 million in Q1 2026, $9.3 million in Q4 2025, and $9.7 million in Q3 2025.